Amphastar Pharmaceuticals Quick Ratio 2012-2024 | AMPH
Historical quick ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years.
| Amphastar Pharmaceuticals Quick Ratio Historical Data |
| Date |
Current Assets - Inventory |
Current Liabilities |
Quick Ratio |
| 2024-09-30 |
$0.42B |
$0.16B |
2.61 |
| 2024-06-30 |
$0.36B |
$0.14B |
2.63 |
| 2024-03-31 |
$0.44B |
$0.26B |
1.72 |
| 2023-12-31 |
$0.38B |
$0.23B |
1.70 |
| 2023-09-30 |
$0.43B |
$0.26B |
1.68 |
| 2023-06-30 |
$0.28B |
$0.25B |
1.11 |
| 2023-03-31 |
$0.30B |
$0.11B |
2.88 |
| 2022-12-31 |
$0.28B |
$0.10B |
2.90 |
| 2022-09-30 |
$0.28B |
$0.10B |
2.75 |
| 2022-06-30 |
$0.28B |
$0.10B |
2.69 |
| 2022-03-31 |
$0.27B |
$0.11B |
2.35 |
| 2021-12-31 |
$0.23B |
$0.10B |
2.17 |
| 2021-09-30 |
$0.20B |
$0.10B |
2.08 |
| 2021-06-30 |
$0.21B |
$0.13B |
1.71 |
| 2021-03-31 |
$0.20B |
$0.13B |
1.60 |
| 2020-12-31 |
$0.18B |
$0.11B |
1.63 |
| 2020-09-30 |
$0.17B |
$0.10B |
1.73 |
| 2020-06-30 |
$0.16B |
$0.09B |
1.74 |
| 2020-03-31 |
$0.14B |
$0.08B |
1.67 |
| 2019-12-31 |
$0.15B |
$0.09B |
1.61 |
| 2019-09-30 |
$0.16B |
$0.09B |
1.84 |
| 2019-06-30 |
$0.19B |
$0.10B |
1.83 |
| 2019-03-31 |
$0.15B |
$0.11B |
1.35 |
| 2018-12-31 |
$0.15B |
$0.11B |
1.41 |
| 2018-09-30 |
$0.13B |
$0.10B |
1.34 |
| 2018-06-30 |
$0.11B |
$0.09B |
1.24 |
| 2018-03-31 |
$0.11B |
$0.07B |
1.53 |
| 2017-12-31 |
$0.12B |
$0.07B |
1.85 |
| 2017-09-30 |
$0.11B |
$0.06B |
1.86 |
| 2017-06-30 |
$0.12B |
$0.06B |
1.87 |
| 2017-03-31 |
$0.11B |
$0.07B |
1.56 |
| 2016-12-31 |
$0.10B |
$0.06B |
1.72 |
| 2016-09-30 |
$0.10B |
$0.06B |
1.64 |
| 2016-06-30 |
$0.09B |
$0.07B |
1.42 |
| 2016-03-31 |
$0.09B |
$0.07B |
1.41 |
| 2015-12-31 |
$0.11B |
$0.06B |
1.76 |
| 2015-09-30 |
$0.13B |
$0.07B |
1.79 |
| 2015-06-30 |
$0.12B |
$0.07B |
1.78 |
| 2015-03-31 |
$0.12B |
$0.07B |
1.63 |
| 2014-12-31 |
$0.12B |
$0.06B |
1.85 |
| 2014-09-30 |
$0.13B |
$0.06B |
2.02 |
| 2014-06-30 |
$0.11B |
$0.06B |
1.92 |
| 2014-03-31 |
$0.10B |
$0.07B |
1.35 |
| 2013-12-31 |
$0.10B |
$0.07B |
1.58 |
| 2013-09-30 |
$0.00B |
|
0.00 |
| 2013-06-30 |
$0.00B |
|
0.00 |
| 2013-03-31 |
$0.00B |
|
0.00 |
| 2012-12-31 |
$0.11B |
$0.06B |
1.90 |
| 2012-09-30 |
$0.00B |
|
0.00 |
| 2012-06-30 |
$0.00B |
|
0.00 |
| 2012-03-31 |
$0.00B |
|
0.00 |
| 2011-12-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.894B |
$0.644B |
|
Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California.
|
